Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Smart investors averaged down over the years and have much more value now.
It’s a Jeopardy answer
What the hell is going on?
That site is a joke.
I completely agree that a partnership will happen before anything. This is what created the value for Lipitor before they bought W/L
It’s still long term
This was your post from last years Presidents Week. We will see.
Scripts Update for Week Ending 23/02
V
TRx: 23,668 {vs 23,635; +0.14%} Sector -0.19%
NRx: 9,262 {vs 9,361; -1.06%} Sector -1.83%
Ref: 14,406 {vs 14,274; +0.92%} Sector +0.89%
GenL
TRx: 48,956 {vs 48,822; +0.27%}
NRx: 18,811 {vs 19,045; -1.23%}
L
TRx: 3,197 {vs 3,505; -8.79%}
NRx: 1,357 {vs 1,574; -13.79%}
V TRx Market Share: 31.22% vs 31.11%
V NRx Market Share: 31.47% vs 31.22%
V Ref Market Share: 31.05% vs 31.04%
What was the earful?
I hope you’re right, but I won’t bet on that.
Agree
All your points are the reason why I said $100 by January 2021. After approval and everything else brewing, it’ll take a couple years to see the real value.
Another BS lawsuit. Maybe Sharma started this. LOL
85% $110 Jan 2021
During the summer months I know make sure I get it out of that oven immediately. LOL
Agree. The only time I smelled it was it was delivered in the Arizona heat and then the capsules broke.
Did I say he was blowing up every BP for a M&A? Like I said, they are having ongoing discussions. Anyone who thinks otherwise is completely delusional.
They’re not engaging in M&A? Sure they are. Anyone who thinks they aren’t talking to BP is delusional.
Same complex as J&J
John, can you please post the text?
Exactly
I have a personal take on joint pain. Prior to starting Vascepa in 2012 I had massive wrist pain. Throughout the first few years it slowly got better with flare ups now and then. The last couple years I’ve been getting flare ups considerably less and no pain in the last 6 months.
They would be foolish to sell at $40/sh.
Jelis was 19% without MO placebo with a population that’s healthier. You’re a complete dumb ass.
You have one more follower now
I don’t think one needs to be a rocket scientist to figure that out.
Reply from Pomerantz Law:
Apparently you didn’t read what I wrote.
Sent from my iPhone
On Nov 16, 2018, at 11:42 AM, Robert Willoughby <rswilloughby@pomlaw.com> wrote:
Dear Mr. Naccarato,
Thank you for contacting us regarding Amarin Corporation.
We would like to file a complaint on your behalf.
There is no cost to you or any shareholder to join or participate in the class action.
The next step would entail you sending us copies of all your trade confirmations detailing your purchases and or sale of the shares and completing the attached certification form to join in on the class action filing.
Please confirm that you have not provided this information to another law firm regarding this case and that you have not sought to be a lead plaintiff in another case within the past 3 years?
For more information on our company, you may visit our website at www.pomlaw.com.
Best regards,
Robert Willoughby
Investor Relations Manager
POMERANTZ LLP
600 Third Avenue, 20th Floor
New York, NY 10016
Tel. 212.661.1100, ext. 9980
Fax 646-355-0083
www.pomlaw.com
rswilloughby@pomlaw.com
-----Original Message-----
From: Mike Naccarato <naccarato.mike@gmail.com>
Sent: Wednesday, November 14, 2018 3:20 PM
To: Robert Willoughby <rswilloughby@pomlaw.com>
Subject: Amarin
Your firm should be ashamed. You actually have the guts to investigate a class action lawsuit against Amarin? Thanks to your notification yesterday the stock dropped 20% on this BS. You actually have the guts to quote a SeekingAlpha article? That is a complete joke. I have been a long-term shareholder of Amarin and I am appalled by your firm’s behavior. I firmly believe in the science and so do 90% of cardiologist after the REDUCE-IT study was announced. Learn your facts before you do something ridiculous like this ever again.
Sent from my iPhone
This email and any attachments thereto, is intended only for use by the addressee(s) named herein and may contain legally privileged and/or confidential information. If you are not the intended recipient of this email, you are hereby notified any dissemination, distribution or copying of this email, and any attachments thereto, is strictly prohibited. If you receive this email in error please immediately notify me at (212) 661-1100 and permanently delete all copies of the email and any attachments.
<Amarin Shareholder Certification (00301731xC40C2).pdf>
<Amarin Complaint (00301554xC40C2).docx>
Nigerian. That’s funny
If that’s the case I thank them both or one in the same.
More than likely. I won’t waste my time with the prick
Nothing yet and doubtful he does. I personally think we should all bombard him.
Yep. That dude is an Ass Hat. I looked him up and he’s a real doctor unlike that Fake Bot called Eileen Eulick. She’s a freak show.
Sounds like Anchor is back on the table sooner rather than later.
I sent this Robert Willoughby yesterday.
Your firm should be ashamed. You actually have the guts to investigate a class action lawsuit against Amarin? Thanks to your notification yesterday the stock dropped 20% on this BS. You actually have the guts to quote a SeekingAlpha article? That is a complete joke. I have been a long-term shareholder of Amarin and I am appalled by your firm’s behavior. I firmly believe in the science and so do 90% of cardiologist after the REDUCE-IT study was announced. Learn your facts before you do something ridiculous like this ever again.
Sent from my iPhone
That will fail. Wait until EVAPORATE comes out the end of next year. That will prove the difference with Vascepa.
Watch @JAMA_current medical news reporter, @jenabbasi, discuss new findings with Eric Peterson, MD, MPH, on the benefits (or lack thereof) of #supplements and #fishoil for cardiovascular disease #AHA18 pic.twitter.com/8pzhJo5E7x
— JAMA Cardiology (@JAMACardio) November 14, 2018
Damn law firm. Kicked it down even more. Maybe should should sue the law firm.
No you’re not.